Herbal treatments have a long standing tradition for a range of gastrointestinal conditions. In contrast, the scientific evidence for the use of herbal preparations is mixed. Available studies are plagued by methodological limitations. For functional gastrointestinal disorders there is evidence for the use of some well characterized preparations. In inflammatory bowel disease (IBD) there are limited placebo controlled trials, other studies use active controls with suboptimal doses of the comparators.
INTRODUCTION
Herbal remedies are widely used for a variety of gastrointestinal and non gastrointestinal disorders. This is reflected by a growing number of publications in this field ( Figure 1) . A recent Cochrane review reported the prevalence of complementary and alternative medicine (CAM) usage for countries in the European Community ranges between 0.3 and 86%. 1 Dissatisfaction with conventional therapies appeared to be the most common reason for CAM use. 1 A survey in patients with inflammatory bowel disease (IBD) conducted in Italy observed that out of a cohort of 705 patients, 126 had used herbal or complementary therapies 2 . The majority of these patients did not experience an improvement of symptoms as the result of the alternative therapies. A Canadian study 3 involving 150 IBD patients reported use of CAM therapies by 60% of patients. This included 31% relying on exercise, diet, and prayer; this latter group was more likely to be older and female. However it is noteworthy that complementary treatments were predominantly used for symptoms such as pain/cramps (64%), diarrhea (60%), and gas/bloating (21%). Those using alternative therapies were not characterised by more intense health care utilisation, but had experienced insufficient symptom relief utilising chemically defined therapies. Comparing use in various countries, it appears that use was greater among North American patients than European patients. 4 
History of herbs and disease
Herbal medicine can be considered to be part of the oldest form of healthcare and herbal was used by herbalists for the treatment of dropsy and heart disease. 5 Even the newer antimalarial drugs were developed from the discovery and isolation of artemisinin from the Artemisia annua plant which has been systematically used in China for almost 2000 years 6 .
While knowledge about herbal therapies was initially passed by word-of-mouth this knowledge was first documented in 1200 BC during the late Shang dynasty 7 .
The effects of herbal medicine for a variety of conditions was used and studied in the middle ages by benectine monks (i.e. Codex Bambergensis Medicinalis). 8 Other famous work was done by Benedictine abbott Walafrid Strabo (Liber de Cultura hortum) published long before M A N U S C R I P T
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-4-print was invented. 9 A similar collection of information is the Speyer Herbal book which is believed to be authored by Hildegrad von Bingen. 10 Although many flowers and aromatic plants were grown for decorative purposes, other plants such as rosemary, aniseed, caraway, cumin, coriander, fennel laurel and mustard were cultivated in the herbal gardens of the monasteries and were used in the kitchens or pharmacies of these monasteries. It is interesting to note that the School of Medicine at Salerno in Southern Italy was in close contact with the nearby monastery of Monte Cassino.
At that time the 'Antidotarium Nicolai Salernitani', written about 1100 was a remarkable collection of herbal recipes that were used by physicians. In the first version it contained 60
formulae. 
Challenges with herbal medicines
It is evident that while experience and systematic observation had provided the platform to formulate treatment recommendations using herbals, it must be recognised that the underlying pathophysiologic concepts or pharmacologic modes of action were not known.
Modern evidence based medicine targets well defined disease mechanisms with highly standardized synthetic medicines. To a large degree this has replaced herbal medicines.
The advantages are evident. Optimal doses of pharmacological active ingredients can be administered, potential ingredients of herbal mixtures that may cause adverse events are eliminated and the activity or concentration (dose) of the treatment is not influenced by metereological variation (e.g. sun exposure), the seasons, or the physical composition of the soil in which plants are grown.
On the other hand, in many Asian and African countries, large proportions of the population depend on traditional medicine for primary health care. Interestingly, herbal medicines are the most lucrative form of traditional medicine, generating billions of dollars in revenue and are used to treat a large variety of conditions. Standardized extraction conditions may be applied and relevant quality parameters monitored such as drug-to-extract ratio (DER), the quality of the herbal drug (water content, content of extractable substances), the extraction solvent (concentration, time flow) and the procedure conditions (time, temperature, pressure). These all play a part in defining product quality. [15] [16] [17] [18] These parameters need to be well defined and standardized to ensure quality standards of the product.
While chemically defined treatments target defined pathophysiologies, not all conditions and diseases have as yet comprehensively defined pathophysiological mechanisms that can be cured with a short term pharmacologic intervention. In gastroenterology, functional gastrointestinal disorders fit into this category.
Complementary and Alternative Medicine
CAM is widely used in the general population and in patients with chronic disorders such as inflammatory bowel disease. 4, 19 On the other hand, the efficacy of chemically defined drugs is limited in the treatment of patients with functional gastrointestinal disorders. As a consequence there is an unmet treatment need for treatment to manage patients with irritable bowel syndrome (IBS) and functional dyspepsia, and for many years herbal medications have been used in many countries for this purpose. A google search of the term "herbal treatment for dyspepsia" revealed more than 1 millions hits. This compared to 1.7 million hits for "PPI treatment for reflux" . There has been a steady increase in publications for complementary and alternative and herbal medicine over the past 30 years ( Figure 1 ).
Herbal treatments for functional gastrointestinal disorders
There are a number of clinical trials focussing on the effects of herbal medicines in patients with functional dyspepsia 20-34 (Table 2 ) and IBS [35] [36] [37] [40] [41] (table 3) . Most studies suggest efficacy of these herbal preparations. However, not all outcome parameters were assessed utilising validated instruments and blinding of herbal preparations is a critical problem of virtually all herbal trials. However it is important to note that in a matched-pair study a higher quality of placebo-controlled trials was shown for herbal medicines compared with conventional medicine.
Overall, compared to chemically defined treatments, the number of trials focusing on functional dyspepsia and IBS is limited. One meta-analysis assessed the evidence for xiaoyao san (MXS) for treating functional dyspepsia (FD). The total effective rate of symptom improvement in this study for MXS ranged from 82.6% to 93.7%. Furthermore symptoms were reduced by a combination of MXS and prokinetic drugs compared to prokinetic drugs alone (odds ratio 4.32, 95% CI 2.64 to 7.08). However, there was evidence for publication bias and methodological flaws, which may have amplified the therapeutic benefit of MXS. 39 Another study assessed a fixed combination of peppermint oil (90 mg) and caraway oil (50 mg) in a cohort of less than 50 patients with functional dyspepsia and found that this resulted in significant improvement of symptoms compared to placebo. 31 Placebo-controlled trials (Table 2 ) have reported significant improvement of symptoms in functional dyspepsia during treatment with specific herbal preparations 20-24, 26-28,30-33 One study showed a significant improvement in FD symptoms with chios mastic gum over placebo. 25 Another study showed improvement in FD and psychological symptoms with xinwei decoction compared with domperidone and placebo. 23 Artichoke leaf extract has been shown to improve FD symptoms and quality of life. 33 The results from studies in IBS (Table 2) however have been more mixed. [35] [36] [37] A meta-analysis has also shown that supplementation of peppermint oil, in addition to pharmacological standard treatments, was of benefit to both constipation predominant IBS and diarrhea predominant IBS patients. 42 Another study showed a significant long lasting improvement of Chinese herbal medicine (standardized and individualised) compared to placebo in IBS. 36 However one study utilising traditional Chinese medicine extracts from 11 herbs failed to find a global improvement in symptoms in patients with diarrhea predominant IBS over placebo. 41 It could be that the use of extracts rather than raw herbs may account for this descrepancy with some unknown yet important component being lost in the water extraction process. Also the placebo in this study did contain a very small amount of lactose.
Others have found no therapeutic benefit of curcuma xanthorriza or fumaria officinalis over placebo in the treatment of IBS related pain or distension. 40 Major problems of alternative medicines are related to a lack of standardization of the compounds, the inclusion of multiple potentially active extracts, and lack of knowledge about their long-term safety and precise mechanisms of action. 43 balm leaves, angelica root, celandine herbs, milk thistle fruit and is produced according to GMP standards and was tested in several clinical trials and has been shown to be superior to placebo in the treatment of functional dyspepsia. 44 The use of STW5 has also been found to be effective over placebo in the treatment of IBS symptoms.
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Mechanistic studies
While some data in relation to clinical efficacy and some in vitro studies exist, very little work has been done to characterize effects of herbal medicines in humans. As shown in table 1 one clinical study 45 observed an increased in the motility index of antral pressure waves in the first 60 minutes after administration of STW5. However, retention of liquids in the stomach was slightly increased but there was no effect on gastric emptying of solids or 
Herbal treatments for inflammatory bowel disease (IBD)
Many herbal preparations have immunomodulatory effects. [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] Thus it appears reasonable to trial herbal medications in patients with IBD. On the other hand, good, large clinical trials testing the effects of herbal therapy in IBD are widely lacking. In a very small randomised placebo controlled study in patients with mild to moderate active ulcerative colitis, sigmoidoscopic scores and laboratory variables showed no significant differences between aloe vera and placebo. However, clinical remission, or improvement and response of symptoms occurred in 30%, 37% and 47%, of 30 patients randomised to receive aloe vera compared to 7% (P<0.1), 7% ([P<0.06) and 14% (P < 0.05), of 14 patients taking placebo. 58 Curmarin is a member of the ginger family (Zingiberaceae). The curcuminoids are natural phenols that are responsible for the yellow color of turmeric. A recent Cochrane analysis reviewed the existing analyses and found that only one trial fulfilled the entry criteria. 59 In the curcumin group 22% relapsed compared to 32% in the control group (P = 0.31). However it was noted that the endoscopic appearance of the mucosa at six months was significantly better in the curcumin group than in the control group. The authors of the Cochrane review concluded that curcumin may be a safe and effective therapy for maintenance of remission, but more data are required.
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-9-A herbal treatment with myrrh, dry extract of chamomile flowers and coffee charcoal has anti-inflammatory and antidiarrheal potential. In a randomised trial with a study population of less than 100, no inferiority with regard to the ability to maintain remission for this mixed preparation compared to the gold standard therapy mesalazine, was found. 60 The study
showed that 22 patients treated with mesalizine experienced a relapse compared to 25 treated with the herbal preparation. It needs to be noted that the gain over placebo is usually less than 20% with mesalazine 61 and typical studies recruited several hundred patients to demonstrate a significant difference. In addition, well controlled studies demonstrate that higher doses (e.g. mesalazine 3.0 g OD are superior to the 0.5 g tid) are significantly better compared to 3 x 0.5 tid. 62 While traditional medicines such as oral 5-aminosalicylic acid drugs, oral corticosteroids and particularly the recent emergence of biological therapies have been found to be effective in inducing remission in IBD patients, these treatments have also been associated with varying cost effectiveness outcomes. 63 Thus, future research studies should also seek to compare the cost effectivness of herbal preparations to the newer chemically defined approaches for the treatment of IBD.
Adverse events related to herbal medicines
It needs to be noted that there are numerous case reports on adverse events related to herbal medicines. [64] [65] [66] [67] These adverse events range from allergic reactions, [68] [69] gastrointestinal side effects, 70 acute hepatitis 71 or other serious adverse events including Stevens-Johnson syndrome, anaphylactic shock and exfoliative dermatitis including reactions that may necessitate hospital admissions. 72 There have also been reports of hepatotoxicity. A critical review by Teschke et al. 73 revealed that many different herbs and herbal products have been implicated to cause toxic liver disease, however significant issues with the quality of these studies renders it difficult to determine whether the herbs were actually causal. Unlike other medications most herbal preparations are not regulated by the same legal and regulatory framework that applies for other medications and as such there is no mandatory reporting of adverse events. As a consequence only a very small proportion of adverse events might be recognised. Indeed, in a study conducted in the UK, more than 500
herbalists of the UK Register of Chinese Herbal Medicine were invited to participate in a study where each were to approach 10 consecutive patients and recruit them for over the 4-week period. However, in this survey no serious adverse events were reported. 74 It is important to note that the available published information strongly suggests that safety of herbal medicines cannot be taken for granted. They should be regulated in a similar way as chemically defined over-the-counter drugs.
Conclusions
Herbal medicines are widely used, predominately as over the counter preparations. The main driver for the use of herbal and complementary medicines is the unmet need of patients. This is in particular evident for functional gastrointestinal disorders. While there is relatively solid evidence for some herbal preparations, many trials conducted in this field have substantial methodological deficiencies such as sample sizes, blinding and assessment of outcome parameters.
On the other hand it must be acknowledged that most preparations tested are not patentable drugs and therefore the financial return of investments into clinical trials utilising widely used herbal preparations is very unlikely. As a consequence there is limited investment of producer and distributors of herbal medicines to further explore efficacy and safety of herbal medicines. It must also be acknowledged that the effect of herbal medicines may not simply result from the combination of various known active ingredients, but the effect of as yet unrecognised biologically active components of a particular herbal preparation. Due to the complexity of chemical components and potential actions, a comprehensive understanding of herbal drugs remains a challenge. To address this, research in this field requires a comprehensive systems approach in order to identify active ingredients and their targets. 81 The widespread notion that herbal therapies are non-effective but safe might not be correct.
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